Replies to post #15550 on Marker Therapeutics Inc (MRKR)

[pharmeng]

Check out ADXS and ADRO for other cancer vaccine companies with PD-1 combos too. They both fell in price recently and are holding a lot of cash. Good opportunity as well.

[lasers]

Tapimmune Hu-Fr-alpha-vaccine IND: 14546 (TPIV200)

https://biz.yahoo.com/e/150727/tpiv8-k.html

The Mayo Foundation granted this license in exchange for an initial upfront payment of $350,000, which was made on July 21, 2015. Upon the payment of the initial upfront payment, the Mayo Foundation assigned to us IND # 14546, and we assumed all responsibility and liability for this investigative new drug application. In addition to the initial upfront payment, we are to pay additional upfront payments, an annual license maintenance fee, milestone fees and royalty fees (which will be subject to a minimum annual royalty fee once royalty fees are due).

[lasers]

It pays for Mayo Clinic to support $TPIV with grant monies as Mayo receives Royalties and Milestone payments, when/and if, TPIV200 is granted Commercial Approval by the FDA.